LIfT BioSciences reports a substantial increase in cancer killing with the addition of a HER2 targeting CAR to its IMAN cell therapy Today 2:00 AM ET (Thomson Reuters ONE)Print LIfT BioSciences reports a substantial increase in cancer killing with the addition of a HER2 targeting CAR to its IMAN cell therapy - Positive data supports the potential of the iN-LIfT platform to produce a variety of genetically engineered CAR-IMANs to enhance killing and more targeted immunomodulation for different...